Free tool
FAERS Monitor: Exjade
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 021882 or its brand name (Exjade, Deferasirox). Reports on generic versions are filed under their own applications.
Reports
22,940
Serious
20,778
91% of reports
Hospitalization
9,063
Death reported
7,078
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- death4,237
- diarrhoea2,082
- sickle cell anaemia with crisis1,617
- pyrexia1,362
- nausea1,273
- haemoglobin decreased1,252
- pneumonia1,152
- serum ferritin increased1,072
- malaise1,020
- vomiting1,003
- fatigue980
- abdominal pain829
- pain826
- blood creatinine increased771
- anaemia731
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2005 | 1 |
| 2006 | 379 |
| 2007 | 336 |
| 2008 | 402 |
| 2009 | 2,043 |
| 2010 | 2,487 |
| 2011 | 3,027 |
| 2012 | 2,694 |
| 2013 | 831 |
| 2014 | 1,693 |
| 2015 | 2,168 |
| 2016 | 1,311 |
| 2017 | 941 |
| 2018 | 750 |
| 2019 | 559 |
| 2020 | 553 |
| 2021 | 552 |
| 2022 | 656 |
| 2023 | 458 |
| 2024 | 452 |
| 2025 | 373 |
| 2026 | 274 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,031,219 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| serum ferritin increasedSignal | 1,072 | 233.6 | 218.7 | 197,698 |
| sickle cell anaemia with crisisSignal | 1,617 | 104.7 | 99.6 | 149,087 |
| haemoglobin decreasedSignal | 1,252 | 11.3 | 10.7 | 11,664 |
| blood creatinine increasedSignal | 771 | 10.9 | 10.2 | 6,897 |
| deathSignal | 4,237 | 4.5 | 4.4 | 12,075 |
| pyrexiaSignal | 1,362 | 3.6 | 3.4 | 2,612 |
| anaemiaSignal | 731 | 3.5 | 3.3 | 1,326 |
| abdominal painSignal | 829 | 3.3 | 3.1 | 1,318 |
| pneumoniaSignal | 1,152 | 3.3 | 3.1 | 1,835 |
| diarrhoeaSignal | 2,082 | 3.0 | 2.8 | 2,783 |
| malaiseSignal | 1,020 | 2.1 | 2.0 | 626 |
| vomiting | 1,003 | 2.0 | 1.8 | 479 |
| nausea | 1,273 | 1.5 | 1.4 | 202 |
| pain | 826 | 1.2 | 1.2 | 37 |
| fatigue | 980 | 1.2 | 1.1 | 21 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.